Another single cell analysis of CML LSCs throughout the course of therapy uncovered that LSCs which persisted after prolonged TKIs treatment presented transforming growth factor β (TGF-β)- and tumor necrosis factor α (TNF-α)-related gene expression signature [27]. This evidence concerns the gene TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive.